APOE and Alzheimer disease: Also, neuroinflammation is a key feature in AD,45 and APOE ε4 carriers have increased levels of plasma inflammatory markers compared to noncarriers, and may also have a differential regulation of neuroinflammatory responses compared to other APOE isoforms.46,47 WMH might be a consequence of neuroinflammation.48